$17.17
0.18[1.06%]
At close: Apr 19
$17.17
0[0.00%]
After Hours: 4:00PM EDT
Core Laboratories
(NYSE:CLB)Core Laboratories Stock (NYSE:CLB), Analyst Ratings, Price Targets, Predictions
Core Laboratories Inc has a consensus price target of $21.33, established from looking at the 25 latest analyst ratings. The last 3 analyst ratings were released from B of A Securities, Stifel, and Stifel on April 15, 2024, February 5, 2024, and January 29, 2024. With an average price target of $18 between B of A Securities, Stifel, and Stifel, there's an implied 4.83% upside for Core Laboratories Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
Stifel
Citigroup
Piper Sandler
Morgan Stanley
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Core Laboratories
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/15/2024 | CLB | Buy Now | Core Laboratories | $17.17 | -6.81% | B of A Securities | Chase Mulvehill | $17 → $16 | Maintains | Underperform | Get Alert |
| 02/05/2024 | CLB | Buy Now | Core Laboratories | $17.17 | -0.99% | Stifel | Stephen Gengaro | $21 → $17 | Maintains | Hold | Get Alert |
| 01/29/2024 | CLB | Buy Now | Core Laboratories | $17.17 | 22.31% | Stifel | Stephen Gengaro | $23 → $21 | Maintains | Hold | Get Alert |
| 09/18/2023 | CLB | Buy Now | Core Laboratories | $17.17 | 16.48% | Citigroup | Scott Gruber | $21 → $20 | Maintains | Sell | Get Alert |
| 07/31/2023 | CLB | Buy Now | Core Laboratories | $17.17 | 22.31% | Piper Sandler | Luke Lemoine | $19 → $21 | Maintains | Neutral | Get Alert |
| 06/30/2023 | CLB | Buy Now | Core Laboratories | $17.17 | 22.31% | Citigroup | Scott Gruber | $22 → $21 | Downgrade | Neutral → Sell | Get Alert |
| 05/01/2023 | CLB | Buy Now | Core Laboratories | $17.17 | 10.66% | Piper Sandler | Luke Lemoine | $18 → $19 | Maintains | Neutral | Get Alert |
| 04/28/2023 | CLB | Buy Now | Core Laboratories | $17.17 | 45.6% | Stifel | Stephen Gengaro | $24 → $25 | Maintains | Hold | Get Alert |
| 04/18/2023 | CLB | Buy Now | Core Laboratories | $17.17 | 25.22% | B of A Securities | Chase Mulvehill | → $21.5 | Downgrade | Neutral → Underperform | Get Alert |
| 02/07/2023 | CLB | Buy Now | Core Laboratories | $17.17 | 51.43% | Citigroup | Scott Gruber | $21 → $26 | Maintains | Neutral | Get Alert |
| 01/09/2023 | CLB | Buy Now | Core Laboratories | $17.17 | — | B of A Securities | Chase Mulvehill | — | Upgrade | Underperform → Neutral | Get Alert |
| 10/07/2022 | CLB | Buy Now | Core Laboratories | $17.17 | — | Citigroup | Scott Gruber | — | Upgrade | Sell → Neutral | Get Alert |
| 09/26/2022 | CLB | Buy Now | Core Laboratories | $17.17 | 16.48% | Morgan Stanley | Connor Lynagh | → $20 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 08/01/2022 | CLB | Buy Now | Core Laboratories | $17.17 | 16.48% | Morgan Stanley | Connor Lynagh | $22 → $20 | Maintains | Equal-Weight | Get Alert |
| 07/13/2022 | CLB | Buy Now | Core Laboratories | $17.17 | 28.13% | Morgan Stanley | Connor Lynagh | $32 → $22 | Maintains | Equal-Weight | Get Alert |
| 05/02/2022 | CLB | Buy Now | Core Laboratories | $17.17 | 86.37% | Morgan Stanley | Connor Lynagh | $35 → $32 | Maintains | Equal-Weight | Get Alert |
| 04/18/2022 | CLB | Buy Now | Core Laboratories | $17.17 | 24.05% | Piper Sandler | Ian Macpherson | $19.5 → $21.3 | Downgrade | Neutral → Underweight | Get Alert |
| 04/11/2022 | CLB | Buy Now | Core Laboratories | $17.17 | 103.84% | Morgan Stanley | Connor Lynagh | $30 → $35 | Maintains | Equal-Weight | Get Alert |
| 01/18/2022 | CLB | Buy Now | Core Laboratories | $17.17 | 74.72% | Morgan Stanley | Connor Lynagh | $32 → $30 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Core Laboratories (CLB)?
The latest price target for Core Laboratories (NYSE: CLB) was reported by B of A Securities on April 15, 2024. The analyst firm set a price target for $16.00 expecting CLB to fall to within 12 months (a possible -6.81% downside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Core Laboratories (CLB)?
The latest analyst rating for Core Laboratories (NYSE: CLB) was provided by B of A Securities, and Core Laboratories maintained their underperform rating.
When was the last upgrade for Core Laboratories (CLB)?
The last upgrade for Core Laboratories Inc happened on January 9, 2023 when B of A Securities raised their price target to N/A. B of A Securities previously had an underperform for Core Laboratories Inc.
When was the last downgrade for Core Laboratories (CLB)?
The last downgrade for Core Laboratories Inc happened on June 30, 2023 when Citigroup changed their price target from $22 to $21 for Core Laboratories Inc.
When is the next analyst rating going to be posted or updated for Core Laboratories (CLB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Core Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Core Laboratories was filed on April 15, 2024 so you should expect the next rating to be made available sometime around April 15, 2025.
Is the Analyst Rating Core Laboratories (CLB) correct?
While ratings are subjective and will change, the latest Core Laboratories (CLB) rating was a maintained with a price target of $17.00 to $16.00. The current price Core Laboratories (CLB) is trading at is $17.17, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.